Medico Intercontinental Ltd
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
- Market Cap ₹ 25.2 Cr.
- Current Price ₹ 25.2
- High / Low ₹ 43.0 / 20.6
- Stock P/E 11.3
- Book Value ₹ 40.8
- Dividend Yield 0.00 %
- ROCE 8.14 %
- ROE 4.30 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.62 times its book value
- Promoter holding has increased by 1.36% over last quarter.
- Company's working capital requirements have reduced from 129 days to 90.7 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 5.83% over past five years.
- Company has a low return on equity of 5.51% over last 3 years.
- Contingent liabilities of Rs.33.8 Cr.
- Earnings include an other income of Rs.3.01 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.27 | 0.23 | 2.03 | 0.00 | 9.95 | 46.93 | 41.02 | 39.25 | 48.88 | 44.04 | 67.13 | 54.45 | 55.32 | |
| 0.27 | 0.32 | 1.97 | 0.34 | 9.27 | 44.73 | 38.68 | 36.98 | 46.38 | 41.44 | 62.83 | 51.32 | 52.78 | |
| Operating Profit | 0.00 | -0.09 | 0.06 | -0.34 | 0.68 | 2.20 | 2.34 | 2.27 | 2.50 | 2.60 | 4.30 | 3.13 | 2.54 |
| OPM % | 0.00% | -39.13% | 2.96% | 6.83% | 4.69% | 5.70% | 5.78% | 5.11% | 5.90% | 6.41% | 5.75% | 4.59% | |
| 0.00 | 0.00 | -0.05 | 0.39 | 0.36 | 0.02 | 0.16 | 0.18 | 0.34 | 0.42 | 0.50 | 2.35 | 3.01 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.66 | 0.78 | 0.52 | 0.37 | 0.22 | 0.67 | 1.67 | 1.72 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.10 | 0.09 | 0.18 | 0.56 | 0.69 | 0.63 |
| Profit before tax | 0.00 | -0.09 | 0.01 | 0.05 | 1.03 | 1.54 | 1.66 | 1.83 | 2.38 | 2.62 | 3.57 | 3.12 | 3.20 |
| Tax % | -33.33% | 0.00% | 40.00% | 26.21% | 27.27% | 27.71% | 28.42% | 28.15% | 27.48% | 28.29% | 29.81% | ||
| 0.00 | -0.06 | 0.01 | 0.03 | 0.76 | 1.12 | 1.20 | 1.31 | 1.70 | 1.90 | 2.57 | 2.18 | 2.23 | |
| EPS in Rs | 0.00 | -0.18 | 0.03 | 0.09 | 2.34 | 3.45 | 3.69 | 4.03 | 1.70 | 1.90 | 2.57 | 2.18 | 2.23 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | 6% |
| 3 Years: | 4% |
| TTM: | -20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -33% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves | 0.04 | -0.02 | -0.01 | 0.02 | 0.78 | 1.90 | 3.09 | 4.40 | 24.30 | 26.10 | 28.66 | 30.85 |
| 0.02 | 0.23 | 0.02 | 0.02 | 0.09 | 8.56 | 4.81 | 6.21 | 2.27 | 0.96 | 13.22 | 16.15 | |
| 0.02 | 0.07 | 0.93 | 0.62 | 5.00 | 5.46 | 5.27 | 3.85 | 7.81 | 2.39 | 6.89 | 10.42 | |
| Total Liabilities | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 58.77 | 67.42 |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.12 | 0.24 | 0.20 | 0.48 | 0.33 | 4.39 | 1.52 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 3.57 | 4.35 | 4.20 | 4.20 | 4.20 | 7.19 | 12.42 |
| 3.33 | 3.53 | 4.18 | 3.90 | 9.09 | 15.48 | 11.83 | 13.31 | 39.70 | 34.92 | 47.19 | 53.48 | |
| Total Assets | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 58.77 | 67.42 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.96 | 0.12 | -0.04 | 0.02 | 0.95 | -6.55 | 5.44 | 1.10 | -11.95 | 5.73 | -6.78 | 15.43 | |
| 0.00 | 0.00 | -0.01 | 0.00 | -0.03 | -3.68 | -0.94 | -0.80 | -5.02 | -6.65 | -4.78 | 8.25 | |
| 3.00 | 0.00 | 0.00 | 0.00 | 0.07 | 9.22 | -4.51 | 0.87 | 20.63 | -1.63 | 10.57 | -22.94 | |
| Net Cash Flow | 0.04 | 0.12 | -0.05 | 0.02 | 0.99 | -1.01 | -0.02 | 1.17 | 3.66 | -2.54 | -0.99 | 0.74 |
| Free Cash Flow | -2.96 | 0.12 | -0.05 | 0.02 | 0.95 | -6.69 | 5.26 | 1.04 | -12.32 | 5.70 | -8.66 | 19.94 |
| CFO/OP | -100% | -67% | -6% | 169% | -286% | 253% | 76% | -452% | 244% | -134% | 527% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 79.35 | 339.83 | 237.34 | 98.54 | 71.45 | 78.86 | 186.08 | 123.74 | 123.81 | 120.19 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 25.84 | 22.28 | 36.32 | 26.47 | 31.98 | 45.60 | 19.14 | 16.86 |
| Days Payable | 200.54 | 45.26 | 51.21 | 39.76 | 64.82 | 19.26 | 36.38 | 72.30 | ||||
| Cash Conversion Cycle | 0.00 | 79.35 | 339.83 | 62.63 | 75.57 | 56.56 | 65.57 | 153.24 | 150.08 | 106.56 | 64.75 | |
| Working Capital Days | 4,352.96 | 4,760.87 | 345.22 | 78.50 | 76.45 | 56.86 | 63.61 | 154.65 | 141.89 | 155.01 | 90.70 | |
| ROCE % | 0.00% | -2.66% | 1.79% | 1.53% | 28.07% | 24.68% | 19.63% | 18.79% | 10.91% | 7.71% | 9.56% | 8.14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of permanent employees on rolls (standalone) employees |
|
|||||||||
| Number of wholly owned subsidiaries subsidiaries |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 42nd AGM voting results on September 30, 2026; all seven ordinary resolutions passed.
- Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after Q2 FY26 results.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Notice Of The 42Nd Annual General Meeting Of The Company.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.